Industry

Biocytogen to Present at BioJapan2022, Introducing Innovative R&D Platforms, Bispecific ADC Programs and Pipeline Progress

BEIJING–(BUSINESS WIRE)–#ADC–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will host a seminar at the BioJapan2022 Conference on Friday, October 14. The seminar, consisting of 3 modules, will introduce: Five RenMiceTM-based fully human antibody discovery platforms: RenMabTM-based monoclonal antibody platform, RenLite®-based bispecific antibody and bispecific ADC platforms, TCR-mimic platform, and GPCR platform Progress of Project … [Read more…]

Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital

Work begins on modern inpatient behavioral health treatment and education facility in Metro Detroit, slated to open in 2024 WEST BLOOMFIELD, Mich.–(BUSINESS WIRE)–Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, broke ground today on a state-of-the-art behavioral health treatment and … [Read more…]

Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers

Approval also marks the second NGS-based companion diagnostic to identify RET-fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC) CARLSBAD, Calif.–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET-fusion positive … [Read more…]

Nick Christianson Joins Kyros as Chief Financial Officer

Career healthcare finance executive brings extensive experience to Kyros, a first of its kind digital platform for recovery services, as first C-suite hire. MINNEAPOLIS–(BUSINESS WIRE)–Kyros, the nation’s first of its kind digital platform for people and organizations within the recovery community, has added Nick Christianson as Chief Financial Officer. Nick is the first C-Suite hire … [Read more…]

BIOQUAL Declares Dividend

ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL’s Board of Directors has declared a dividend of $1.00 per share for shareholders of record on October 6, 2022, payable on October 27, 2022. This is the twenty-first dividend declared by BIOQUAL. Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements … [Read more…]

Four out of ten Americans report significant gap between culture their workplace claims to have versus their reality

Supported by TELUS Health, LifeWorks’ Mental Health Index™ finds negative workplace culture impacts mental health and leads to two and a half times less productivity than positive environments CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions supported by TELUS Health, today released its monthly Mental Health Index™ revealing that four out … [Read more…]

University of Phoenix nursing faculty leadership Dr. Sun Jones recipient of March of Dimes HEROES IN ACTION Leadership Award

Award recognizes Dr. Jones’ exceptional leadership in community contributions PHOENIX–(BUSINESS WIRE)–University of Phoenix celebrates that College of Nursing faculty Sun Jones, DNP, RN, FNP-BC, who serves as the Systematic Plan for Evaluation and Curriculum leader, is the recipient of the 2022 March of Dimes Arizona HEROES IN ACTION Leadership Award. The March of Dimes Arizona … [Read more…]

Immunis Chairman Dr. Hans Keirstead Presents United Nations General Assembly Keynote on Behalf of the National Institute of Child Sexual Assault

IRVINE, Calif.–(BUSINESS WIRE)–#CSA–Immunis, Inc., a private biotech company generating an innovative treatment for age and disease-related immune decline, announces that its Chairman, Dr. Hans Keirstead, delivered a keynote on behalf of the National Institute of Child Sexual Assault (NICSA) at the UN General Assembly in New York City. As part of Immunis’ ongoing Corporate Social … [Read more…]

Henry Schein Opens Customer Assistance Hotline in Response to Hurricane Ian

Dentists and Physicians Who May Experience Operational, Logistical, or Financial Issues Encouraged to Call 800-999-9729 MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Ian that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, … [Read more…]

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

IHEEZO™ Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14 Years  IHEEZO™ was Licensed by Harrow for the U.S. and Canadian Markets From 100-Year-Old International Pharmaceutical Company Sintetica, S.A. NASHVILLE, Tenn. & MENDRISIO, Switzerland–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: … [Read more…]